Karl Staser
Indiana University School of MedicineIndiana University – Purdue University Indianapolis(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Neurofibromatosis and Schwannoma Cases, Hematopoietic Stem Cell Transplantation, Immune Cell Function and Interaction, T-cell and B-cell Immunology
Most-Cited Works
- → An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies(2018)385 cited
- → Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial(2012)232 cited
- → Erk1 Positively Regulates Osteoclast Differentiation and Bone Resorptive Activity(2011)125 cited
- → Mast cells and the neurofibroma microenvironment(2010)118 cited
- → The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia(2017)108 cited
- → Pathogenesis of Plexiform Neurofibroma: Tumor-Stromal/Hematopoietic Interactions in Tumor Progression(2011)108 cited
- → A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation(2014)107 cited
- → A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease(2020)95 cited
- → A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity(2022)90 cited
- → Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease(2018)89 cited